Abstract:Qinghe Zeng, 1, 2, &ast Qi Sun, 3, &ast Huihui Xu, 1, 2, &ast Jiali Chen, 1 Houfu Ling, 4 Qinwen Ge, 1, 2 Kaiao Zou, 1, 2 Xu Wang, 1, 2 Hongting Jin, 1 Ju Li, 4, &ast Minwei Jin 4, &ast 1 Institute of Orthopedics and Traumatology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 2 The First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 3 Department of Orthopaedic Surgery, Fuyang Orthopaedics and Traumatology Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China; 4 Department of Orthopaedics, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Minwei Jin; Ju Li, Email ; Background: Intervertebral disc degeneration (IDD) is a major cause of lower back pain (LBP), in which inflammatory is frequently involved. Amygdalin (AMD) is a naturally occurring compound that exerts anti-fibrotic, anti-inflammatory, analgesic, and immunomodulatory effects in various diseases. The purpose of this study was to investigate the therapeutic effects and molecular mechanisms of AMD on Lumbar spine instability (LSI)-induced IDD in mice. Methods: In this study, we first explored the effects of AMD in vivo, and then further explored the mechanism of its effects both in vivo and in vitro. Ten-week-old male C57BL/6J mice were administrated with AMD. At 10 weeks after LSI, spinal were collected for tissue analyses, including histology, micro-CT, and immunohistochemistry for Col2, Mmp-13, TNF-α, and p-P65. Additionally, we also evaluated the mRNA and protein expression level of p-P65 and p-IKBα after being treated with AMD in vitro. Results: Histological staining, micro-CT and immunohistochemical analysis showed that AMD treatment significantly inhibited the expression of TNF-α and Mmp-13, increased the expression of Col2 as well as attenuated the calcification of cartilage endplates, eventually to delayed the progression of IDD. Meanwhile, in vivo and in vitro fluorescence imaging revealed that AMD markedly inhibited the AMD significantly inhibited the LSI-induced increase in TNF-α expression and P65and IKBα phosphorylation. Discussion: Our findings suggest that AMD partly inhibits the activation of NF-κB signaling pathway to reduce the release of inflammatory mediators and delay the degeneration of cartilage endplate in IDD model mice. Therefore, AMD may be a potential candidate for the treatment of IDD. Keywords: intervertebral disc degeneration, amygdalin, cartilage endplate, inflammatory processes, NF-κB pathway Low back pain (LBP) is one of the common orthopaedic diseases in daily life, and its prevalence is increasing with age, and it is also related to excessive exercise. 1,2 This not only affects people's quality of life but also increases the burden of social medical resources. 3 As research has found, disc degeneration is closely linked to LBP and is one of the main causes of LBP. 4 However, the exact mechanism of Intervertebral disc degeneration (IDD) has not yet been elucidated. 5 The intervertebral disc (IVD) is a fibrocartilaginous disc between two adjacent pyramids, consisting of the nucleus pulposus (NP), the annulus fibrosus (AF), and the upper and lower cartilage endplates (CEP). Modern studies have found that IDD is mainly manifested in the reduction of the number of NP cells, abnormal ECM metabolism, reduction of type II collagen, and calcification and death of endplate chondrocytes, etc. 6 Nowadays, the therapeutic strategies to treat IVD degeneration and assuage IDD-related pain include conservative treatments, such as anti-inflammatory drugs. When these treatments prove themselves inefficient, radical surgical interventions (eg disc removal and spinal fusion) are considered. These changes are closely related to the inflammatory response mediated by cellular inflammatory factors. Inflammation not only reduces the synthesis of extracellular matrix such as proteoglycans and type II collagen but also promotes the expression of matrix metalloproteinases (MMPs), which further reduces the biological properties of cartilage endplates and eventually leads to IDD. 7–9 For example, administration of Chlorogenic Acid (CGA) mitiga -Abstract Truncated-

Transcriptomics Study to Determine the Molecular Mechanism by Which Sil-13Rα2-fc Inhibits Caudal Intervertebral Disc Degeneration in Rats

The Role of Mir-31-5p in the Development of Intervertebral Disc Degeneration and Its Therapeutic Potential.

Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration

TNF-α and IL-1β Promote a Disintegrin-like and Metalloprotease with Thrombospondin Type I Motif-5-mediated Aggrecan Degradation Through Syndecan-4 in Intervertebral Disc

Inactivation of Tnf-α/Tnfr signaling attenuates progression of intervertebral disc degeneration in mice

MMPs and ADAMTSs in Intervertebral Disc Degeneration

TNF‐α Induces Up‐regulation of MicroRNA‐27a Via the P38 Signalling Pathway, Which Inhibits Intervertebral Disc Degeneration by Targeting FSTL1

Collagen II enrichment through scAAV6-RNAi-mediated inhibition of matrix-metalloproteinases 3 and 13 in degenerative nucleus-pulposus cells degenerative disc disease and biological treatment strategies

Adamts-5 and Intervertebral Disc Degeneration: the Results of Tissue Immunohistochemistry and in Vitro Cell Culture

The Imbalance Between TIMP3 and Matrix-Degrading Enzymes Plays an Important Role in Intervertebral Disc Degeneration.

Bioinformatics Analysis of Molecular Mechanisms Involved in Intervertebral Disc Degeneration Induced by TNF-α and IL-1β.

IL-17A Enhances ADAMTS-7 Expression Through Regulation of TNF-α in Human Nucleus Pulposus Cells.

Alarmins S100A8/A9 Promote Intervertebral Disc Degeneration and Inflammation-Related Pain in a Rat Model Through Toll-Like Receptor-4 and Activation of the NF-κB Signaling Pathway.

IL-1β Promotes ADAMTS Enzyme-Mediated Aggrecan Degradation Through NF-κB in Human Intervertebral Disc

Identifying the protective effects of miR‐874‐3p/ATF3 axis in intervertebral disc degeneration by single‐cell RNA sequencing and validation

Elevated Lymphotoxin-Α (tnfβ) is Associated with Intervertebral Disc Degeneration

FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro

The Proteolysis of ECM in Intervertebral Disc Degeneration

Amygdalin Delays Cartilage Endplate Degeneration and Improves Intervertebral Disc Degeneration by Inhibiting NF-κB Signaling Pathway and Inflammatory Response

Role of the miR-133a-5p/FBXO6 axis in the regulation of intervertebral disc degeneration

Alpha 2-Macroglobulin as Dual Regulator for Both Anabolism and Catabolism in the Cartilaginous Endplate of Intervertebral Disc